7th Annual Pharmacovigilance Conference 2012

Key Topics

• Surveillance of adverse drug reactions in clinical trials
• Pharmacovigilance from clinical development to patient care
• Risk management plans for improving drug safety
• Pharmacovigilance activities in biopharmaceutical product development
• Regulations in the EU, US and Asia
• Good pharmacovigilance practice through advances in audits and inspections
• Post marketing surveillance
• The role of the QPPV and patient safety
• Periodic Safety Update Reports (PSURs)
• Methods of reporting
• Pharmacogenetics and the potential for personalised medicines
• Signal detection in pharmacovigilance

Who should Attend

Managers, executives, Consultants and Scientific Advisors involved in Pharmacoepidemiology, Pharmacovigilance, Drug/Product Safety, Pharmacogenomics, Information and Clinical Data Management, Drug Development, Clinical Safety, Clinical Pharmacology, Risk Management, Periodical safety update reports, Quality Assurance, Research & Development, Signal Detection, Patient Safety, Outcomes Research, Safety Surveillance, Epidemiology, Data Analysis, Regulatory Affairs and Compliance, Medical Affairs, Sales and Marketing and Information technology.